دورية أكاديمية
Eflornithine (Iwilfin) for high-risk neuroblastoma.
| العنوان: | Eflornithine (Iwilfin) for high-risk neuroblastoma. |
|---|---|
| المصدر: | The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 May 13; Vol. 66 (1702), pp. e81-e82. Date of Electronic Publication: 2024 May 13. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Electronic Cited Medium: Internet ISSN: 1523-2859 (Electronic) Linking ISSN: 0025732X NLM ISO Abbreviation: Med Lett Drugs Ther Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New Rochelle, NY : The Medical Letter |
| مواضيع طبية MeSH: | Neuroblastoma*/drug therapy , Eflornithine*/therapeutic use , Eflornithine*/administration & dosage , Eflornithine*/adverse effects, Humans ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/administration & dosage |
| فهرسة مساهمة: | Keywords: Iwilfin; adverse effects; dosage; efficacy; eflornithine; lactation; neuroblastoma; pregnancy; safety |
| المشرفين على المادة: | ZQN1G5V6SR (Eflornithine) 0 (Antineoplastic Agents) |
| تواريخ الأحداث: | Date Created: 20240502 Date Completed: 20240502 Latest Revision: 20240502 |
| رمز التحديث: | 20240503 |
| DOI: | 10.58347/tml.2024.1702f |
| PMID: | 38696315 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1523-2859 |
|---|---|
| DOI: | 10.58347/tml.2024.1702f |